Infectious Agents and Cancer (Oct 2020)

A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing

  • Andrew Goldstein,
  • Yang Lei,
  • Lena Goldstein,
  • Amelia Goldstein,
  • Qiao Xu Bai,
  • Juan Felix,
  • Roberta Lipson,
  • Maria Demarco,
  • Mark Schiffman,
  • Didem Egemen,
  • Kanan T. Desai,
  • Sarah Bedell,
  • Janet Gersten,
  • Gail Goldstein,
  • Karen O’Keefe,
  • Casey O’Keefe,
  • Tierney O’Keefe,
  • Cathy Sebag,
  • Lior Lobel,
  • Anna Zhao,
  • Yan Ling Lu

DOI
https://doi.org/10.1186/s13027-020-00329-0
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Objective Rapid, high-volume screening programs are needed as part of cervical cancer prevention in China. Methods In a 5-day screening project in Inner Mongolia, 3345 women volunteered following a community awareness campaign, and self-swabbed to permit rapid HPV testing. Two AmpFire™ HPV detection systems (Atila Biosystems) were sufficient to provide pooled 15-HPV type data within an hour. HPV+ patients had same-day digital colposcopy (DC) performed by 1 of 6 physicians, using the EVA™ system (MobileODT). Digital images were obtained and, after biopsy of suspected lesions for later confirmatory diagnosis, women were treated immediately based on colposcopic impression. Suspected low- grade lesions were offered treatment with thermal ablation (Wisap), and suspected high-grade lesions were treated with LLETZ. Results Of 3345 women screened, 624 (18.7%) were HPV+. Of these, 88.5% HPV+ women underwent same-day colposcopy and 78 were treated. Later consensus histology results obtained on 197 women indicated 20 CIN2+, of whom 15 were detected and treated/referred at screening (10 by thermal ablation, 4 by LLETZ, 1 by referral). Conclusions Global control of cervical cancer will require both vaccination and screening of a huge number of women. This study illustrates a cervical screening strategy that can be used to screen-and-treat large numbers of women. HPV self-sampling facilitates high-volume screening. Specimens can be tested rapidly, promoting minimal loss-to-follow-up. Specifically, the AmpFire™ system used in this study is highly portable, simple, rapid (92 specimens per 65 min per unit), and economical. Visual triage can be performed on HPV+ women with a portable digital colposcope that provides magnification, lighting, and a recorded image. Diagnosis and appropriate treatment remain the most subjective elements. The digital image is under study for deep-learning based automated evaluation that could assist the management decision, either by itself or combined with HPV typing.